Sarcopenic obesity: definition, cause and consequences.
Abstract
PURPOSE OF REVIEW:
Older obese persons with decreased muscle mass or strength are at special risk for adverse outcomes. We discuss potential pathways to muscle impairment in obese individuals and the consequences that joint obesity and muscle impairment may have on health and disability. Tantamount to this discussion is whether low muscle mass or, rather, muscle weakness should be used for the definition.
RECENT FINDINGS:
Excess energy intake, physical inactivity, low-grade inflammation, insulin resistance and changes in hormonal milieu may lead to the development of so-called 'sarcopenic obesity'. It was originally believed that the culprit of age-related muscle weakness was a reduction in muscle mass, but it is now clear that changes in muscle composition and quality are predominant. We propose that the risk of adverse outcomes, such as functional limitation and mortality, is better estimated by considering jointly obesity and muscle strength rather than obesity and muscle mass and the term 'sarcopenic obesity' should be revisited.
SUMMARY:
Recognition of obese patients who have associated muscle problems is an essential goal for clinicians. Further research is needed to identify new target for prevention and cure of this important geriatric syndrome.
Main Authors
Format
Articles
Research article
Published
2008
Series
Subjects
Publication in research information system
The permanent address of the publication
https://urn.fi/URN:NBN:fi:jyu-201909114104Käytä tätä linkitykseen.
Review status
Peer reviewed
ISSN
1473-6519
DOI
https://doi.org/10.1097/MCO.0b013e328312c37d
Language
English
Published in
Current Opinion in Clinical Nutrition & Metabolic Care
Citation
- Stenholm, S., Harris, T., Rantanen, T., Visser, M., Kritchevsky, S. B., & Ferrucci, L. (2008). Sarcopenic obesity: definition, cause and consequences.. Current Opinion in Clinical Nutrition & Metabolic Care, 11(6), 693-700. https://doi.org/10.1097/MCO.0b013e328312c37d
Copyright© 2008 Wolters Kluwer Health, Lippincott Williams & Wilkins